During the past decade, Jin Wook Yi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jin Wook Yi" #1 collaborator was "Green Cross Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jin Wook Yi" are "Surgical Wound Infection" (1 trials), "Thoracic Duct Leak" (1 trials), "Thyroid Cancer" (1 trials), "Thyroid Gland Carcinoma" (1 trials) and "Thyroid Nodule" (1 trials). Many other conditions were trialed in "Jin Wook Yi" in a lesser frequency.

Most popular intervention types in "Jin Wook Yi" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amoxicillin Clavulanate" (1 trials) and "Neoveil (Polyglycolic Acid Mesh)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jin Wook Yi" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jin Wook Yi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jin Wook Yi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jin Wook Yi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".